A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver：RFA Versus Laparoscopic Hepatectomy.
N/A
18 Years
65 Years
18 Years
65 Years
Open (Enrolling)
Both
Laparoscopic Hepatectomy, Radio-frequency Ablation, Giant Cavernous Hemangiomas, Liver
Both
Laparoscopic Hepatectomy, Radio-frequency Ablation, Giant Cavernous Hemangiomas, Liver
Trial Information
A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver：RFA Versus Laparoscopic Hepatectomy.
Inclusion Criteria:
- giant cavernous hemangiomas with a diameter larger than or equal to 5 cm diagnosed by
more than one imaging modalities
- age between 18 years to 65 years
- without gender restriction
- PLT account more than 50 e9
- without abnormal of liver function test
- with substantial evidence of growing size than before
- symptom associated cavernous hemangiomas
- with a strong desire of the patients for the treatment
Exclusion Criteria:
- pregnant women
- abnormal of liver function or coagulation dysfunction and/or concurrent with sever
cardiac or pulmonary disorders
- patient with a poor condition that can't bear the approach of either RFA or
laparoscopic hepatectomy
- tumor size more than 20cm
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
disappearance rate of disease
Outcome Description:
to determine the disappearance rate of disease by imaging modality using enhanced Ultrasound examine and/or enhanced CT
Outcome Time Frame:
1 month
Safety Issue:
No
Authority:
China: Ethics Committee
Study ID:
swhb004
NCT ID:
NCT01471080
Start Date:
November 2011
Completion Date:
March 2013
Related Keywords:
- Laparoscopic Hepatectomy
- Radio-frequency Ablation
- Giant Cavernous Hemangiomas
- Liver
- laparoscopic hepatectomy
- radio-frequency ablation
- giant cavernous hemangiomas
- liver
- Hemangioma
- Hemangioma, Cavernous
Name | Location |
|---|
